Objectives-To investigate the role of T helper-i cell (Thl) activation in the induction of proinflammatory cytokine production and cartilage damage by rheumatoid arthritis (RA) synovial fluid mononuclear cells (SFMNC) and the subsequent possible beneficial role of the T helper-2 cell (Th2) cytokine interleukin-4 (IL-4) in the inhibition of this process. Methods-SFMNC were stimulated with bacterial antigen (hsp6O) to activate Thl cells. Thl and Th2 specific cytokine profiles (interferon gamma (IFN'y) and IL-4) and proinflammatory cytokines interleukin-l (IL-1) and tumour necrosis factor a (TNFa) in the conditioned media were analysed. In addition, the conditioned media were tested for their ability to induce cartilage damage. The same parameters were measured in the presence of IL-4. Results-Stimulation of SFMNC with bacterial antigen resulted in an increase in IFNy, IL-1, and TNFa production which was accompanied by the induction of cartilage damage. Thl activation could be inhibited by IL-4 as shown by a reduction of IFNy. This was accompanied by a decrease in IL-1 and TNFa production and inhibition of cartilage damage. Conclusions-Thl activation is a possible mechanism by which inflammation in RA joints is enhanced. The Th2 cytokine IL-4 inhibits this Thl activity and may diminish inflammation and induction of cartilage damage in RA joints.
Thl activity has been demonstrated in joints of patients with bacteria induced arthritis such as Lyme's arthritis and reactive arthritis.7-9 Bacterial infections (slowgrowing) have been implicated in RA."' In RA patients, reactivity of synovial fluid mononuclear cells (MNC) towards bacterial antigens such as the mycobacterial heat shock proteins (hsp) has been demonstrated. '1-13 Antigens of Mycobacterium tuberculosis and M lepra, like the mycobacterial hsp6O have been shown to induce Thl cells selectively.'4 '5 In several studies it has been demonstrated that RA is accompanied by Thi activity. '6'-9 In the RA joint, T cells can influence macrophage activity. Stimulated synovial macrophages contribute to inflammatory processes and production of proinflammatory cytokines such as IL-1 and tumour necrosis factor ax (TNFax), causing damage to the articular cartilage. 20 Netherlands for IL-4). The limits of detection of the assay were 1 IU/ml for IFN-y, 1 pg/ml for IL-4, 10 pg/ml for TNFoa, and 10 pg/ml for IL-1.
CARTILAGE TISSUE CULTURE
Macroscopically normal postmortem cartilage was obtained from the central part of human femoral knee condyles within 24 hours after death of the donor. Donors were aged 47-85 years (mean 65 years) (n = 8). As far as could be determined from the patients' medical records, these donors had not been treated for joint disorders. Pieces of cartilage, as thick as possible, were cut from condyles of both knees, excluding underlying bone. The slices obtained were kept in phosphate buffered saline (PBS, pH 7-4). Within one hour after dissection they were cut into squares, weighed aseptically (5-15 mg, accuracy 0 1 mg) and transferred to the culture medium (see above). Individual explants were cultured randomly, eightfold, in 96 well microtitre plates (200 Ru/well). They were precultured for 24 hours, the media were refreshed, then during a culture period of four days the effects of the addition of IL-4, conditioned media of SFMNC, or SFMNC (coculture) on cartilage proteoglycan (PG) turnover were tested by determination of the rate of synthesis and release of PG. IL-4 was added in concentrations of 2 and 20 U/ml. Conditioned media of SFMNC were tested in concentrations of 5% (v/v). Isolated RA SFMNC were cocultured with cartilage in a concentration of 2 103 cells/ml.
DETERMINATION OF RATE OF PROTEOGLYCAN SYNTHESIS
As a measure of PG synthetic activity of the chondrocytes, incorporation of sulphate was determined during a four hour period before termination of the experiment. Procedures were followed as described previously using 35SO42-as a tracer and cetylpyridinium chloride to precipitate glycosaminoglycan (GAG) in a papain digest of cartilage explants. 30 The total sulphate incorporation rate was calculated from the 35SO42-incorporation rate and the specific activity of the medium, and was normalised to the wet weight of the sample. were also inhibited by IL-4 significantly and dose dependently, by up to 53% (fig 2) . If bacterial antigen did not stimulate SFMNC to inhibit PG synthesis (n = 3) (fig 1) , no changes were observed on addition of IL-4 (data not shown). In particular, addition of is: effect IL-4 to these non-responding SFMNC did not expressed produce a change in IFN-y levels, which 2 by remained below the limit of detection. SFMNC that responded to bacterial antigen (inhibited PG synthesis). A dose dependent statistically significant reduction in IL-l and TNFot by up to 68% and 30%, respectively, -100
was seen upon addition of IL-4. IL-i and TNFot levels from the conditioned media of non-responding SFMNC, not inhibiting PG synthesis, remained below the limit of detection (data not shown). Lyme's arthritis. We have demonstrated that activation of Thl cells by bacterial antigen within a population of RA SFMNC was accompanied specifically by the production of IFN-y (not of IL-4), and was associated with an increase in the production of IL-1 and TNFot. As a result of this activation, cartilage damage was induced. This occurred in coculture, and indirectly when the effects of conditioned media of stimulated SFMNC were tested on cartilage turnover. In the present study (data not shown) and earlier studies using neutralising antibodies, we have shown that both IL-1 and TNFot activity produced during this stimulation are, indeed, predominant inducers of cartilage damage.33 It appeared that not all patients responded to the bacterial antigen, regardless of disease parameters or medication as had been reported previously. micro-organisms are beneficial to patients suffering from these infections: Thl activation supports cell mediated cytotoxicity that is necessary to combat these micro-organisms. In contrast, in diseases in which autoreactive Th 1 responses to self antigens predominate, this immune response is harmful to the patient. In several animal models for autoimmune diseases, such as multiple sclerosis and insulin dependent diabetes, it has been demonstrated that autoimmune responses are Thl mediated.34 Downregulation of Thl activity and upregulation of Th2 activity by administration of neutralising IFN-y antibodies or IL-4 has been shown to prevent the induction and cause remission of inflammatory responses in these experimental autoimmune diseases.34 Similarly, it has been shown that remission of collagen induced arthritis can be stimulated by addition of IL-4, whereas spontaneous remission is accompanied by a Th2 induced phenomenon (IgE production35).
In 26 42 However, IL-4 has also been reported to be unable to suppress IL-1 and TNFot production. 25 43 This discrepancy may result from differences in the states of activation or differentiation of the target cell used. The present study has shown that IL-4 was able to inhibit production of these cytokines by SFMNC upon antigen induced Thl activation-a relevant observation, as Thl cells, in addition to IL-1 and TNFot, predominate in RA joints.1619 22 On the basis of our observation of IL-4 induced inhibition of Thl activity, proinflammatory cytokine production, and cartilage damage, we conclude that administration of IL-4, and maybe more effectively the upregulation of Th2 cell activity, may be considered for treatment of RA. 
